0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Isoxaflutole(Cas 141112-29-0) Market Insights, Forecast to 2028
Published Date: 2022-02-17
|
Report Code: QYRE-Auto-22N2070
Home | Market Reports
Global Isoxaflutole Cas 141112 29 0 Market Insights Forecast to 2028

Global Isoxaflutole(Cas 141112-29-0) Market Insights, Forecast to 2028

Code: QYRE-Auto-22N2070
Report
2022-02-17
Pages:87
QYResearch
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Isoxaflutole(Cas 141112-29-0) Market

Due to the COVID-19 pandemic, the global Isoxaflutole(Cas 141112-29-0) market size is estimated to be worth US$ 167.7 million in 2022 and is forecast to a readjusted size of US$ 215.8 million by 2028 with a CAGR of 4.3% during the review period.

Fully considering the economic change by this health crisis, Ex-oxidation Method Isoxaflutole accounting for % of the Isoxaflutole(Cas 141112-29-0) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Maize segment is altered to an % CAGR throughout this forecast period.
China Isoxaflutole(Cas 141112-29-0) market size is valued at US$ million in 2021, while the US and Europe Isoxaflutole(Cas 141112-29-0) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Isoxaflutole(Cas 141112-29-0) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Isoxaflutole(Cas 141112-29-0) include Bayer CropScience, DowDuPont, Syngenta, Chemos, Santa Cruz Biotechnology, Wanko Chemical, Aventis CropScience and Zhejiang Corechem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Isoxaflutole(Cas 141112-29-0) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Isoxaflutole(Cas 141112-29-0) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Isoxaflutole(Cas 141112-29-0) Scope and Segment
Isoxaflutole(Cas 141112-29-0) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Isoxaflutole(Cas 141112-29-0) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Ex-oxidation Method Isoxaflutole
Post-oxidation Method Isoxaflutole

Segment by Application

Maize
Sugarcane
Other Crops

BY COMPANY

Bayer CropScience
DowDuPont
Syngenta
Chemos
Santa Cruz Biotechnology
Wanko Chemical
Aventis CropScience
Zhejiang Corechem

Production by Region

North America
Europe
China
Japan

Consumption by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Isoxaflutole(Cas 141112-29-0) Product Introduction
1.2 Market by Type
1.2.1 Global Isoxaflutole(Cas 141112-29-0) Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Ex-oxidation Method Isoxaflutole
1.2.3 Post-oxidation Method Isoxaflutole
1.3 Market by Application
1.3.1 Global Isoxaflutole(Cas 141112-29-0) Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Maize
1.3.3 Sugarcane
1.3.4 Other Crops
1.4 Study Objectives
1.5 Years Considered
2 Global Isoxaflutole(Cas 141112-29-0) Production
2.1 Global Isoxaflutole(Cas 141112-29-0) Production Capacity (2017-2028)
2.2 Global Isoxaflutole(Cas 141112-29-0) Production by Region: 2017 VS 2021 VS 2028
2.3 Global Isoxaflutole(Cas 141112-29-0) Production by Region
2.3.1 Global Isoxaflutole(Cas 141112-29-0) Historic Production by Region (2017-2022)
2.3.2 Global Isoxaflutole(Cas 141112-29-0) Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Isoxaflutole(Cas 141112-29-0) Sales in Volume & Value Estimates and Forecasts
3.1 Global Isoxaflutole(Cas 141112-29-0) Sales Estimates and Forecasts 2017-2028
3.2 Global Isoxaflutole(Cas 141112-29-0) Revenue Estimates and Forecasts 2017-2028
3.3 Global Isoxaflutole(Cas 141112-29-0) Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Isoxaflutole(Cas 141112-29-0) Sales by Region
3.4.1 Global Isoxaflutole(Cas 141112-29-0) Sales by Region (2017-2022)
3.4.2 Global Sales Isoxaflutole(Cas 141112-29-0) by Region (2023-2028)
3.5 Global Isoxaflutole(Cas 141112-29-0) Revenue by Region
3.5.1 Global Isoxaflutole(Cas 141112-29-0) Revenue by Region (2017-2022)
3.5.2 Global Isoxaflutole(Cas 141112-29-0) Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Isoxaflutole(Cas 141112-29-0) Production Capacity by Manufacturers
4.2 Global Isoxaflutole(Cas 141112-29-0) Sales by Manufacturers
4.2.1 Global Isoxaflutole(Cas 141112-29-0) Sales by Manufacturers (2017-2022)
4.2.2 Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Isoxaflutole(Cas 141112-29-0) in 2021
4.3 Global Isoxaflutole(Cas 141112-29-0) Revenue by Manufacturers
4.3.1 Global Isoxaflutole(Cas 141112-29-0) Revenue by Manufacturers (2017-2022)
4.3.2 Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Isoxaflutole(Cas 141112-29-0) Revenue in 2021
4.4 Global Isoxaflutole(Cas 141112-29-0) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Isoxaflutole(Cas 141112-29-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Isoxaflutole(Cas 141112-29-0) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Isoxaflutole(Cas 141112-29-0) Sales by Type
5.1.1 Global Isoxaflutole(Cas 141112-29-0) Historical Sales by Type (2017-2022)
5.1.2 Global Isoxaflutole(Cas 141112-29-0) Forecasted Sales by Type (2023-2028)
5.1.3 Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Type (2017-2028)
5.2 Global Isoxaflutole(Cas 141112-29-0) Revenue by Type
5.2.1 Global Isoxaflutole(Cas 141112-29-0) Historical Revenue by Type (2017-2022)
5.2.2 Global Isoxaflutole(Cas 141112-29-0) Forecasted Revenue by Type (2023-2028)
5.2.3 Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Type (2017-2028)
5.3 Global Isoxaflutole(Cas 141112-29-0) Price by Type
5.3.1 Global Isoxaflutole(Cas 141112-29-0) Price by Type (2017-2022)
5.3.2 Global Isoxaflutole(Cas 141112-29-0) Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Isoxaflutole(Cas 141112-29-0) Sales by Application
6.1.1 Global Isoxaflutole(Cas 141112-29-0) Historical Sales by Application (2017-2022)
6.1.2 Global Isoxaflutole(Cas 141112-29-0) Forecasted Sales by Application (2023-2028)
6.1.3 Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Application (2017-2028)
6.2 Global Isoxaflutole(Cas 141112-29-0) Revenue by Application
6.2.1 Global Isoxaflutole(Cas 141112-29-0) Historical Revenue by Application (2017-2022)
6.2.2 Global Isoxaflutole(Cas 141112-29-0) Forecasted Revenue by Application (2023-2028)
6.2.3 Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Application (2017-2028)
6.3 Global Isoxaflutole(Cas 141112-29-0) Price by Application
6.3.1 Global Isoxaflutole(Cas 141112-29-0) Price by Application (2017-2022)
6.3.2 Global Isoxaflutole(Cas 141112-29-0) Price Forecast by Application (2023-2028)
7 North America
7.1 North America Isoxaflutole(Cas 141112-29-0) Market Size by Type
7.1.1 North America Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2028)
7.1.2 North America Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2028)
7.2 North America Isoxaflutole(Cas 141112-29-0) Market Size by Application
7.2.1 North America Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2028)
7.2.2 North America Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2028)
7.3 North America Isoxaflutole(Cas 141112-29-0) Sales by Country
7.3.1 North America Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2028)
7.3.2 North America Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Isoxaflutole(Cas 141112-29-0) Market Size by Type
8.1.1 Europe Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2028)
8.1.2 Europe Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2028)
8.2 Europe Isoxaflutole(Cas 141112-29-0) Market Size by Application
8.2.1 Europe Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2028)
8.2.2 Europe Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2028)
8.3 Europe Isoxaflutole(Cas 141112-29-0) Sales by Country
8.3.1 Europe Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2028)
8.3.2 Europe Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Isoxaflutole(Cas 141112-29-0) Market Size by Type
9.1.1 Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2028)
9.1.2 Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2028)
9.2 Asia Pacific Isoxaflutole(Cas 141112-29-0) Market Size by Application
9.2.1 Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2028)
9.2.2 Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2028)
9.3 Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Region
9.3.1 Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Region (2017-2028)
9.3.2 Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Isoxaflutole(Cas 141112-29-0) Market Size by Type
10.1.1 Latin America Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2028)
10.1.2 Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2028)
10.2 Latin America Isoxaflutole(Cas 141112-29-0) Market Size by Application
10.2.1 Latin America Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2028)
10.2.2 Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2028)
10.3 Latin America Isoxaflutole(Cas 141112-29-0) Sales by Country
10.3.1 Latin America Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2028)
10.3.2 Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Market Size by Type
11.1.1 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2028)
11.1.2 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2028)
11.2 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Market Size by Application
11.2.1 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2028)
11.2.2 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2028)
11.3 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Country
11.3.1 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2028)
11.3.2 Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Bayer CropScience
12.1.1 Bayer CropScience Corporation Information
12.1.2 Bayer CropScience Overview
12.1.3 Bayer CropScience Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Bayer CropScience Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Bayer CropScience Recent Developments
12.2 DowDuPont
12.2.1 DowDuPont Corporation Information
12.2.2 DowDuPont Overview
12.2.3 DowDuPont Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 DowDuPont Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 DowDuPont Recent Developments
12.3 Syngenta
12.3.1 Syngenta Corporation Information
12.3.2 Syngenta Overview
12.3.3 Syngenta Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Syngenta Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Syngenta Recent Developments
12.4 Chemos
12.4.1 Chemos Corporation Information
12.4.2 Chemos Overview
12.4.3 Chemos Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Chemos Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Chemos Recent Developments
12.5 Santa Cruz Biotechnology
12.5.1 Santa Cruz Biotechnology Corporation Information
12.5.2 Santa Cruz Biotechnology Overview
12.5.3 Santa Cruz Biotechnology Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Santa Cruz Biotechnology Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Santa Cruz Biotechnology Recent Developments
12.6 Wanko Chemical
12.6.1 Wanko Chemical Corporation Information
12.6.2 Wanko Chemical Overview
12.6.3 Wanko Chemical Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Wanko Chemical Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Wanko Chemical Recent Developments
12.7 Aventis CropScience
12.7.1 Aventis CropScience Corporation Information
12.7.2 Aventis CropScience Overview
12.7.3 Aventis CropScience Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Aventis CropScience Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Aventis CropScience Recent Developments
12.8 Zhejiang Corechem
12.8.1 Zhejiang Corechem Corporation Information
12.8.2 Zhejiang Corechem Overview
12.8.3 Zhejiang Corechem Isoxaflutole(Cas 141112-29-0) Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Zhejiang Corechem Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Zhejiang Corechem Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Isoxaflutole(Cas 141112-29-0) Industry Chain Analysis
13.2 Isoxaflutole(Cas 141112-29-0) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Isoxaflutole(Cas 141112-29-0) Production Mode & Process
13.4 Isoxaflutole(Cas 141112-29-0) Sales and Marketing
13.4.1 Isoxaflutole(Cas 141112-29-0) Sales Channels
13.4.2 Isoxaflutole(Cas 141112-29-0) Distributors
13.5 Isoxaflutole(Cas 141112-29-0) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Isoxaflutole(Cas 141112-29-0) Industry Trends
14.2 Isoxaflutole(Cas 141112-29-0) Market Drivers
14.3 Isoxaflutole(Cas 141112-29-0) Market Challenges
14.4 Isoxaflutole(Cas 141112-29-0) Market Restraints
15 Key Finding in The Global Isoxaflutole(Cas 141112-29-0) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Isoxaflutole(Cas 141112-29-0) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Ex-oxidation Method Isoxaflutole
    Table 3. Major Manufacturers of Post-oxidation Method Isoxaflutole
    Table 4. Global Isoxaflutole(Cas 141112-29-0) Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 5. Global Isoxaflutole(Cas 141112-29-0) Production by Region: 2017 VS 2021 VS 2028 (MT)
    Table 6. Global Isoxaflutole(Cas 141112-29-0) Production by Region (2017-2022) & (MT)
    Table 7. Global Isoxaflutole(Cas 141112-29-0) Production Market Share by Region (2017-2022)
    Table 8. Global Isoxaflutole(Cas 141112-29-0) Production by Region (2023-2028) & (MT)
    Table 9. Global Isoxaflutole(Cas 141112-29-0) Production Market Share by Region (2023-2028)
    Table 10. Global Isoxaflutole(Cas 141112-29-0) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Isoxaflutole(Cas 141112-29-0) Sales by Region (2017-2022) & (MT)
    Table 12. Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Region (2017-2022)
    Table 13. Global Isoxaflutole(Cas 141112-29-0) Sales by Region (2023-2028) & (MT)
    Table 14. Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Region (2023-2028)
    Table 15. Global Isoxaflutole(Cas 141112-29-0) Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Region (2017-2022)
    Table 17. Global Isoxaflutole(Cas 141112-29-0) Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Region (2023-2028)
    Table 19. Global Isoxaflutole(Cas 141112-29-0) Production Capacity by Manufacturers (2017-2022) & (MT)
    Table 20. Global Isoxaflutole(Cas 141112-29-0) Capacity Market Share by Manufacturers (2017-2022)
    Table 21. Global Isoxaflutole(Cas 141112-29-0) Sales by Manufacturers (2017-2022) & (MT)
    Table 22. Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Manufacturers (2017-2022)
    Table 23. Global Isoxaflutole(Cas 141112-29-0) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Global Isoxaflutole(Cas 141112-29-0) Revenue Share by Manufacturers (2017-2022)
    Table 25. Isoxaflutole(Cas 141112-29-0) Price by Manufacturers 2017-2022 (USD/MT)
    Table 26. Global Isoxaflutole(Cas 141112-29-0) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Isoxaflutole(Cas 141112-29-0) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoxaflutole(Cas 141112-29-0) as of 2021)
    Table 28. Isoxaflutole(Cas 141112-29-0) Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers Isoxaflutole(Cas 141112-29-0) Product Offered
    Table 30. Date of Manufacturers Enter into Isoxaflutole(Cas 141112-29-0) Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2022) & (MT)
    Table 33. Global Isoxaflutole(Cas 141112-29-0) Sales by Type (2023-2028) & (MT)
    Table 34. Global Isoxaflutole(Cas 141112-29-0) Sales Share by Type (2017-2022)
    Table 35. Global Isoxaflutole(Cas 141112-29-0) Sales Share by Type (2023-2028)
    Table 36. Global Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Global Isoxaflutole(Cas 141112-29-0) Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Global Isoxaflutole(Cas 141112-29-0) Revenue Share by Type (2017-2022)
    Table 39. Global Isoxaflutole(Cas 141112-29-0) Revenue Share by Type (2023-2028)
    Table 40. Isoxaflutole(Cas 141112-29-0) Price by Type (2017-2022) & (USD/MT)
    Table 41. Global Isoxaflutole(Cas 141112-29-0) Price Forecast by Type (2023-2028) & (USD/MT)
    Table 42. Global Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2022) & (MT)
    Table 43. Global Isoxaflutole(Cas 141112-29-0) Sales by Application (2023-2028) & (MT)
    Table 44. Global Isoxaflutole(Cas 141112-29-0) Sales Share by Application (2017-2022)
    Table 45. Global Isoxaflutole(Cas 141112-29-0) Sales Share by Application (2023-2028)
    Table 46. Global Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Isoxaflutole(Cas 141112-29-0) Revenue by Application (2023-2028) & (US$ Million)
    Table 48. Global Isoxaflutole(Cas 141112-29-0) Revenue Share by Application (2017-2022)
    Table 49. Global Isoxaflutole(Cas 141112-29-0) Revenue Share by Application (2023-2028)
    Table 50. Isoxaflutole(Cas 141112-29-0) Price by Application (2017-2022) & (USD/MT)
    Table 51. Global Isoxaflutole(Cas 141112-29-0) Price Forecast by Application (2023-2028) & (USD/MT)
    Table 52. North America Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2022) & (MT)
    Table 53. North America Isoxaflutole(Cas 141112-29-0) Sales by Type (2023-2028) & (MT)
    Table 54. North America Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2022) & (US$ Million)
    Table 55. North America Isoxaflutole(Cas 141112-29-0) Revenue by Type (2023-2028) & (US$ Million)
    Table 56. North America Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2022) & (MT)
    Table 57. North America Isoxaflutole(Cas 141112-29-0) Sales by Application (2023-2028) & (MT)
    Table 58. North America Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2022) & (US$ Million)
    Table 59. North America Isoxaflutole(Cas 141112-29-0) Revenue by Application (2023-2028) & (US$ Million)
    Table 60. North America Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2022) & (MT)
    Table 61. North America Isoxaflutole(Cas 141112-29-0) Sales by Country (2023-2028) & (MT)
    Table 62. North America Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2022) & (US$ Million)
    Table 63. North America Isoxaflutole(Cas 141112-29-0) Revenue by Country (2023-2028) & (US$ Million)
    Table 64. Europe Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2022) & (MT)
    Table 65. Europe Isoxaflutole(Cas 141112-29-0) Sales by Type (2023-2028) & (MT)
    Table 66. Europe Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2022) & (US$ Million)
    Table 67. Europe Isoxaflutole(Cas 141112-29-0) Revenue by Type (2023-2028) & (US$ Million)
    Table 68. Europe Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2022) & (MT)
    Table 69. Europe Isoxaflutole(Cas 141112-29-0) Sales by Application (2023-2028) & (MT)
    Table 70. Europe Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2022) & (US$ Million)
    Table 71. Europe Isoxaflutole(Cas 141112-29-0) Revenue by Application (2023-2028) & (US$ Million)
    Table 72. Europe Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2022) & (MT)
    Table 73. Europe Isoxaflutole(Cas 141112-29-0) Sales by Country (2023-2028) & (MT)
    Table 74. Europe Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2022) & (US$ Million)
    Table 75. Europe Isoxaflutole(Cas 141112-29-0) Revenue by Country (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2022) & (MT)
    Table 77. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Type (2023-2028) & (MT)
    Table 78. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Type (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2022) & (MT)
    Table 81. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Application (2023-2028) & (MT)
    Table 82. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Region (2017-2022) & (MT)
    Table 85. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales by Region (2023-2028) & (MT)
    Table 86. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Region (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue by Region (2023-2028) & (US$ Million)
    Table 88. Latin America Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2022) & (MT)
    Table 89. Latin America Isoxaflutole(Cas 141112-29-0) Sales by Type (2023-2028) & (MT)
    Table 90. Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Latin America Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2022) & (MT)
    Table 93. Latin America Isoxaflutole(Cas 141112-29-0) Sales by Application (2023-2028) & (MT)
    Table 94. Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Latin America Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2022) & (MT)
    Table 97. Latin America Isoxaflutole(Cas 141112-29-0) Sales by Country (2023-2028) & (MT)
    Table 98. Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2022) & (US$ Million)
    Table 99. Latin America Isoxaflutole(Cas 141112-29-0) Revenue by Country (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Type (2017-2022) & (MT)
    Table 101. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Type (2023-2028) & (MT)
    Table 102. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Type (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Type (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Application (2017-2022) & (MT)
    Table 105. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Application (2023-2028) & (MT)
    Table 106. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Application (2023-2028) & (US$ Million)
    Table 108. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Country (2017-2022) & (MT)
    Table 109. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales by Country (2023-2028) & (MT)
    Table 110. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue by Country (2023-2028) & (US$ Million)
    Table 112. Bayer CropScience Corporation Information
    Table 113. Bayer CropScience Description and Major Businesses
    Table 114. Bayer CropScience Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Bayer CropScience Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Bayer CropScience Recent Development
    Table 117. DowDuPont Corporation Information
    Table 118. DowDuPont Description and Major Businesses
    Table 119. DowDuPont Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. DowDuPont Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. DowDuPont Recent Development
    Table 122. Syngenta Corporation Information
    Table 123. Syngenta Description and Major Businesses
    Table 124. Syngenta Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Syngenta Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Syngenta Recent Development
    Table 127. Chemos Corporation Information
    Table 128. Chemos Description and Major Businesses
    Table 129. Chemos Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. Chemos Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Chemos Recent Development
    Table 132. Santa Cruz Biotechnology Corporation Information
    Table 133. Santa Cruz Biotechnology Description and Major Businesses
    Table 134. Santa Cruz Biotechnology Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. Santa Cruz Biotechnology Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Santa Cruz Biotechnology Recent Development
    Table 137. Wanko Chemical Corporation Information
    Table 138. Wanko Chemical Description and Major Businesses
    Table 139. Wanko Chemical Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Wanko Chemical Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Wanko Chemical Recent Development
    Table 142. Aventis CropScience Corporation Information
    Table 143. Aventis CropScience Description and Major Businesses
    Table 144. Aventis CropScience Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. Aventis CropScience Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Aventis CropScience Recent Development
    Table 147. Zhejiang Corechem Corporation Information
    Table 148. Zhejiang Corechem Description and Major Businesses
    Table 149. Zhejiang Corechem Isoxaflutole(Cas 141112-29-0) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. Zhejiang Corechem Isoxaflutole(Cas 141112-29-0) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Zhejiang Corechem Recent Development
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Isoxaflutole(Cas 141112-29-0) Distributors List
    Table 155. Isoxaflutole(Cas 141112-29-0) Customers List
    Table 156. Isoxaflutole(Cas 141112-29-0) Market Trends
    Table 157. Isoxaflutole(Cas 141112-29-0) Market Drivers
    Table 158. Isoxaflutole(Cas 141112-29-0) Market Challenges
    Table 159. Isoxaflutole(Cas 141112-29-0) Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Isoxaflutole(Cas 141112-29-0) Product Picture
    Figure 2. Global Isoxaflutole(Cas 141112-29-0) Market Share by Type in 2021 & 2028
    Figure 3. Ex-oxidation Method Isoxaflutole Product Picture
    Figure 4. Post-oxidation Method Isoxaflutole Product Picture
    Figure 5. Global Isoxaflutole(Cas 141112-29-0) Market Share by Application in 2021 & 2028
    Figure 6. Maize
    Figure 7. Sugarcane
    Figure 8. Other Crops
    Figure 9. Isoxaflutole(Cas 141112-29-0) Report Years Considered
    Figure 10. Global Isoxaflutole(Cas 141112-29-0) Capacity, Production and Utilization (2017-2028) & (MT)
    Figure 11. Global Isoxaflutole(Cas 141112-29-0) Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 12. Global Isoxaflutole(Cas 141112-29-0) Production Market Share by Region (2017-2022)
    Figure 13. Global Isoxaflutole(Cas 141112-29-0) Production Market Share by Region (2023-2028)
    Figure 14. Isoxaflutole(Cas 141112-29-0) Production Growth Rate in North America (2017-2028) & (MT)
    Figure 15. Isoxaflutole(Cas 141112-29-0) Production Growth Rate in Europe (2017-2028) & (MT)
    Figure 16. Isoxaflutole(Cas 141112-29-0) Production Growth Rate in China (2017-2028) & (MT)
    Figure 17. Isoxaflutole(Cas 141112-29-0) Production Growth Rate in Japan (2017-2028) & (MT)
    Figure 18. Global Isoxaflutole(Cas 141112-29-0) Sales 2017-2028 (MT)
    Figure 19. Global Isoxaflutole(Cas 141112-29-0) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Isoxaflutole(Cas 141112-29-0) Revenue 2017-2028 (US$ Million)
    Figure 21. Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 22. Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Region (2017-2022)
    Figure 23. Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Region (2023-2028)
    Figure 24. North America Isoxaflutole(Cas 141112-29-0) Sales YoY (2017-2028) & (MT)
    Figure 25. North America Isoxaflutole(Cas 141112-29-0) Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Isoxaflutole(Cas 141112-29-0) Sales YoY (2017-2028) & (MT)
    Figure 27. Europe Isoxaflutole(Cas 141112-29-0) Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Isoxaflutole(Cas 141112-29-0) Sales YoY (2017-2028) & (MT)
    Figure 29. Asia-Pacific Isoxaflutole(Cas 141112-29-0) Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Latin America Isoxaflutole(Cas 141112-29-0) Sales YoY (2017-2028) & (MT)
    Figure 31. Latin America Isoxaflutole(Cas 141112-29-0) Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. Middle East & Africa Isoxaflutole(Cas 141112-29-0) Sales YoY (2017-2028) & (MT)
    Figure 33. Middle East & Africa Isoxaflutole(Cas 141112-29-0) Revenue YoY (2017-2028) & (US$ Million)
    Figure 34. The Isoxaflutole(Cas 141112-29-0) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 35. The Top 5 and 10 Largest Manufacturers of Isoxaflutole(Cas 141112-29-0) in the World: Market Share by Isoxaflutole(Cas 141112-29-0) Revenue in 2021
    Figure 36. Isoxaflutole(Cas 141112-29-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 37. Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Type (2017-2028)
    Figure 38. Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Type (2017-2028)
    Figure 39. Global Isoxaflutole(Cas 141112-29-0) Sales Market Share by Application (2017-2028)
    Figure 40. Global Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Application (2017-2028)
    Figure 41. North America Isoxaflutole(Cas 141112-29-0) Sales Market Share by Type (2017-2028)
    Figure 42. North America Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Type (2017-2028)
    Figure 43. North America Isoxaflutole(Cas 141112-29-0) Sales Market Share by Application (2017-2028)
    Figure 44. North America Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Application (2017-2028)
    Figure 45. North America Isoxaflutole(Cas 141112-29-0) Sales Share by Country (2017-2028)
    Figure 46. North America Isoxaflutole(Cas 141112-29-0) Revenue Share by Country (2017-2028)
    Figure 47. U.S. Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 48. Canada Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 49. Europe Isoxaflutole(Cas 141112-29-0) Sales Market Share by Type (2017-2028)
    Figure 50. Europe Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Type (2017-2028)
    Figure 51. Europe Isoxaflutole(Cas 141112-29-0) Sales Market Share by Application (2017-2028)
    Figure 52. Europe Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Application (2017-2028)
    Figure 53. Europe Isoxaflutole(Cas 141112-29-0) Sales Share by Country (2017-2028)
    Figure 54. Europe Isoxaflutole(Cas 141112-29-0) Revenue Share by Country (2017-2028)
    Figure 55. Germany Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 56. France Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 57. U.K. Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 58. Italy Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 59. Russia Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 60. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Type (2017-2028)
    Figure 62. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Application (2017-2028)
    Figure 64. Asia Pacific Isoxaflutole(Cas 141112-29-0) Sales Share by Region (2017-2028)
    Figure 65. Asia Pacific Isoxaflutole(Cas 141112-29-0) Revenue Share by Region (2017-2028)
    Figure 66. China Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 67. Japan Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 68. South Korea Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 69. India Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 70. Australia Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 71. Taiwan Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 72. Indonesia Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 73. Thailand Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 74. Malaysia Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 75. Philippines Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 76. Latin America Isoxaflutole(Cas 141112-29-0) Sales Market Share by Type (2017-2028)
    Figure 77. Latin America Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Type (2017-2028)
    Figure 78. Latin America Isoxaflutole(Cas 141112-29-0) Sales Market Share by Application (2017-2028)
    Figure 79. Latin America Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Application (2017-2028)
    Figure 80. Latin America Isoxaflutole(Cas 141112-29-0) Sales Share by Country (2017-2028)
    Figure 81. Latin America Isoxaflutole(Cas 141112-29-0) Revenue Share by Country (2017-2028)
    Figure 82. Mexico Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 83. Brazil Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 84. Argentina Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 85. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Type (2017-2028)
    Figure 87. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue Market Share by Application (2017-2028)
    Figure 89. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Sales Share by Country (2017-2028)
    Figure 90. Middle East and Africa Isoxaflutole(Cas 141112-29-0) Revenue Share by Country (2017-2028)
    Figure 91. Turkey Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 92. Saudi Arabia Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 93. U.A.E Isoxaflutole(Cas 141112-29-0) Revenue (2017-2028) & (US$ Million)
    Figure 94. Isoxaflutole(Cas 141112-29-0) Value Chain
    Figure 95. Isoxaflutole(Cas 141112-29-0) Production Process
    Figure 96. Channels of Distribution
    Figure 97. Distributors Profiles
    Figure 98. Bottom-up and Top-down Approaches for This Report
    Figure 99. Data Triangulation
    Figure 100. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture
SIMILAR REPORTS